Terug
68
27
88
Dagbereik
€ 7,47
€ 7,77
52-Weeksbereik
€ 7,20
€ 13,47
Volume
398.183
50D / 200D Gem.
€ 10,28
/
€ 10,88
Vorige Slotkoers
€ 7,74
Koershistorie
Financiële Trends
Sectorvergelijking
vs Financial Services sector mediaan (854 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 0,1 | 10,3 |
| P/B | 0,0 | 1,1 |
| ROE % | 35,8 | 11,7 |
| Net Margin % | 20,3 | 16,8 |
| Rev Growth 5Y % | 287,6 | 11,7 |
| D/E | 0,7 | 0,5 |
Insider Trading Activity
17 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 23, 2025 |
Sarsfield Luke A. III
See Remarks
|
other | 556.812 | — | — |
| Sep 26, 2025 |
Abell Alexander I.
|
sell | 25.000 | € 11,23 | € 281.170 |
| Aug 27, 2025 |
Thomas P. Danis, Jr. Revocable Living Trust dated March 10, 2003
|
sell | 21.700 | € 12,37 | € 268.412 |
| Aug 26, 2025 |
Jon I. Madorsky Revocable Trust dated December 1, 2008
|
sell | 50.000 | € 12,45 | € 622.610 |
| Jun 13, 2025 |
Benford Tracey
|
grant | 26.681 | — | — |
| Jun 13, 2025 |
Gwilliam Scott L.
|
grant | 21.345 | — | — |
| Jun 13, 2025 |
Stewart Robert B Jr
|
grant | 21.345 | — | — |
| Jun 13, 2025 |
Barnes Travis H.
|
grant | 19.744 | — | — |
| Jun 13, 2025 |
BLEWITT STEPHEN J
|
grant | 19.744 | — | — |
| Jun 13, 2025 |
Glassman Jennifer T
|
grant | 19.744 | — | — |
| Jun 9, 2025 |
Sarsfield Luke A. III
See Remarks
|
buy | 5.000 | € 9,87 | € 49.350 |
| Jun 9, 2025 |
HOOD MARK C
See remarks
|
buy | 5.000 | € 9,81 | € 49.050 |
| May 16, 2025 |
Abell Alexander I.
|
sell | 31.602 | € 12,21 | € 385.734 |
| May 12, 2025 |
Abell Alexander I.
|
sell | 48.990 | € 12,22 | € 598.805 |
| May 12, 2025 |
Abell Alexander I.
|
other | 178.398 | € 2,96 | — |
| Mar 25, 2025 |
Abell Alexander I.
|
sell | 20.000 | € 12,28 | € 245.520 |
| Mar 25, 2025 |
McCoy David M.
|
sell | 90.000 | € 12,16 | € 1.094.400 |
Belangrijkste Punten
Revenue grew 287,63% annually over 5 years — strong growth
Earnings grew 36787,70% over the past year
ROE of 35,75% indicates high profitability
Net margin of 20,30% shows strong profitability
Generating 5,09B in free cash flow
P/E of 0,12 — trading at a low valuation
Groei
Revenue Growth (5Y)
287,63%
Revenue (1Y)11364,41%
Earnings (1Y)36787,70%
FCF Growth (3Y)949,36%
Kwaliteit
Return on Equity
35,75%
ROIC10,26%
Net Margin20,30%
Op. Margin26,25%
Veiligheid
Debt / Equity
0,71
Current Ratio0,88
Interest Coverage0,00
Waardering
P/E Ratio
0,12
P/B Ratio0,02
EV/EBITDA2,55
Dividend Yield0,61%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11364,41% | Revenue Growth (3Y) | 1085,72% |
| Earnings Growth (1Y) | 36787,70% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 287,63% | Earnings Growth (5Y) | 403,10% |
| Profitability | |||
| Revenue (TTM) | 33,99B | Net Income (TTM) | 6,90B |
| ROE | 35,75% | ROA | 7,95% |
| Gross Margin | 48,83% | Operating Margin | 26,25% |
| Net Margin | 20,30% | Free Cash Flow (TTM) | 5,09B |
| ROIC | 10,26% | FCF Growth (3Y) | 949,36% |
| Safety | |||
| Debt / Equity | 0,71 | Current Ratio | 0,88 |
| Interest Coverage | 0,00 | Dividend Yield | 0,61% |
| Valuation | |||
| P/E Ratio | 0,12 | P/B Ratio | 0,02 |
| P/S Ratio | 0,02 | PEG Ratio | 0,00 |
| EV/EBITDA | 2,55 | Dividend Yield | 0,61% |
| Market Cap | 828,65M | Enterprise Value | 22,76B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 33,99B | 296,45M | 241,73M | 198,36M | 150,53M |
| Net Income | 6,90B | 18,70M | -7,13M | 29,21M | 10,77M |
| EPS (Diluted) | 14,61 | 0,16 | -0,06 | 0,24 | 0,08 |
| Gross Profit | 16,60B | 141,13M | 87,45M | 104,06M | 95,78M |
| Operating Income | 8,92B | 60,62M | 20,92M | 43,42M | 40,35M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 86,82B | 869,28M | 834,07M | 826,36M | 676,22M |
| Total Liabilities | 47,08B | 482,39M | 408,91M | 392,48M | 281,05M |
| Shareholders' Equity | 38,25B | 347,00M | 385,59M | 393,14M | 395,16M |
| Total Debt | 26,99B | 340,37M | 310,12M | 307,78M | 228,20M |
| Cash & Equivalents | 5,06B | 67,46M | 30,47M | 20,02M | 40,92M |
| Current Assets | 13,33B | 189,87M | 116,13M | 86,81M | 61,25M |
| Current Liabilities | 15,20B | 66,76M | 135,01M | 39,74M | 109,53M |
Strategiescores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
#81 of 616
#346 of 658
#17 of 154
Recente Activiteit
Ingestapt
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026
Ingestapt
Growth Investing (Philip Fisher)
Mar 24, 2026